Nova Ltd.
Nova Ltd. (NVMI) Financial Performance & Income Statement Overview
Explore the financials of Nova Ltd. (NVMI), including yearly and quarterly data on income, cash flow, and balance sheets.
Nova Ltd. (NVMI) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Nova Ltd. NVMI financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $213.36M | $194.77M | $178.97M | $156.86M |
| Cost of Revenue | $91.05M | $84.83M | $77.64M | $64.30M |
| Gross Profit | $122.30M | $109.93M | $101.33M | $92.56M |
| Gross Profit Ratio | $0.57 | $0.56 | $0.57 | $0.59 |
| R&D Expenses | $33.23M | $30.91M | $29.08M | $25.51M |
| SG&A Expenses | $25.84M | $23.55M | $23.02M | $21.43M |
| Operating Expenses | $59.07M | $54.46M | $52.10M | $46.94M |
| Total Costs & Expenses | $150.12M | $139.29M | $129.74M | $111.24M |
| Interest Income | $12.94M | $3.76M | $11.03M | $7.96M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4.90M | $4.30M | $4.35M | $4.36M |
| EBITDA | $68.13M | $59.77M | $53.58M | $49.98M |
| EBITDA Ratio | $0.32 | $0.31 | $0.30 | $0.32 |
| Operating Income | $63.23M | $55.47M | $49.23M | $45.62M |
| Operating Income Ratio | $0.30 | $0.28 | $0.28 | $0.29 |
| Other Income/Expenses (Net) | $12.94M | $3.76M | $11.03M | $7.96M |
| Income Before Tax | $76.17M | $59.23M | $60.26M | $53.58M |
| Income Before Tax Ratio | $0.36 | $0.30 | $0.34 | $0.34 |
| Income Tax Expense | $11.35M | $8.75M | $8.98M | $8.44M |
| Net Income | $64.82M | $50.48M | $51.28M | $45.14M |
| Net Income Ratio | $0.30 | $0.26 | $0.29 | $0.29 |
| EPS | $2.22 | $1.72 | $1.76 | $1.55 |
| Diluted EPS | $2.03 | $1.58 | $1.59 | $1.40 |
| Weighted Avg Shares Outstanding | $29.26M | $29.30M | $29.10M | $29.05M |
| Weighted Avg Shares Outstanding (Diluted) | $32.06M | $32.06M | $32.24M | $32.24M |
Over the past four quarters, Nova Ltd. demonstrated steady revenue growth, increasing from $156.86M in Q2 2024 to $213.36M in Q1 2025. Operating income reached $63.23M in Q1 2025, maintaining a consistent 30% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $68.13M, reflecting operational efficiency. Net income rose to $64.82M, with EPS at $2.22. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan